Merit Medical Systems annual gross margin
2009
2010
2011
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Merit Medical Systems's gross margin was 48.70% for fiscal 2025.
View full Merit Medical Systems company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 48.70% | +1.28 pp |
| 2024 | 2024-12-31 | 47.43% | +0.99 pp |
| 2023 | 2023-12-31 | 46.44% | +1.34 pp |
| 2022 | 2022-12-31 | 45.10% | −0.06 pp |
| 2021 | 2021-12-31 | 45.16% | +3.54 pp |
| 2020 | 2020-12-31 | 41.62% | −1.84 pp |
| 2019 | 2019-12-31 | 43.46% | −1.26 pp |
| 2018 | 2018-12-31 | 44.72% | −0.10 pp |
| 2017 | 2017-12-31 | 44.82% | +0.93 pp |
| 2016 | 2016-12-31 | 43.89% | −2.14 pp |
| 2011 | 2011-12-31 | 46.03% | +2.73 pp |
| 2010 | 2010-12-31 | 43.30% | +1.04 pp |
| 2009 | 2009-12-31 | 42.26% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 51.37% | +3.13 pp |
| Q1 2026 | 2026-03-31 | 48.39% | −0.02 pp |
| Q4 2025 | 2025-12-31 | 49.59% | +0.88 pp |
| Q3 2025 | 2025-09-30 | 48.52% | +2.17 pp |
| Q2 2025 | 2025-06-30 | 48.24% | +0.57 pp |
| Q1 2025 | 2025-03-31 | 48.41% | +1.51 pp |
| Q4 2024 | 2024-12-31 | 48.71% | +2.32 pp |
| Q3 2024 | 2024-09-30 | 46.35% | +1.25 pp |
| Q2 2024 | 2024-06-30 | 47.66% | −0.07 pp |
| Q1 2024 | 2024-03-31 | 46.90% | +0.40 pp |
| Q4 2023 | 2023-12-31 | 46.39% | +0.53 pp |
| Q3 2023 | 2023-09-30 | 45.11% | +0.34 pp |
| Q2 2023 | 2023-06-30 | 47.74% | +1.95 pp |
| Q1 2023 | 2023-03-31 | 46.50% | +2.60 pp |
| Q4 2022 | 2022-12-31 | 45.86% | −0.39 pp |
| Q3 2022 | 2022-09-30 | 44.77% | −0.35 pp |
| Q2 2022 | 2022-06-30 | 45.79% | +1.51 pp |
| Q1 2022 | 2022-03-31 | 43.90% | −1.05 pp |
| Q4 2021 | 2021-12-31 | 46.25% | +3.17 pp |
| Q3 2021 | 2021-09-30 | 45.13% | +3.31 pp |
| Q2 2021 | 2021-06-30 | 44.28% | +5.72 pp |
| Q1 2021 | 2021-03-31 | 44.95% | +2.34 pp |
| Q4 2020 | 2020-12-31 | 43.09% | −0.19 pp |
| Q3 2020 | 2020-09-30 | 41.81% | −1.03 pp |
| Q2 2020 | 2020-06-30 | 38.57% | −5.25 pp |
| Q1 2020 | 2020-03-31 | 42.62% | −1.28 pp |
| Q4 2019 | 2019-12-31 | 43.28% | −1.59 pp |
| Q3 2019 | 2019-09-30 | 42.85% | −3.19 pp |
| Q2 2019 | 2019-06-30 | 43.82% | −0.67 pp |
| Q1 2019 | 2019-03-31 | 43.90% | +0.53 pp |
| Q4 2018 | 2018-12-31 | 44.87% | −0.02 pp |
| Q3 2018 | 2018-09-30 | 46.03% | +0.93 pp |
| Q2 2018 | 2018-06-30 | 44.49% | — |
| Q1 2018 | 2018-03-31 | 43.37% | — |
| Q3 2017 | 2017-09-30 | 44.90% | — |
| Q2 2017 | 2017-06-30 | 45.10% | — |
Over the last five reported fiscal years, Merit Medical Systems's gross margin increased from 41.62% to 48.70%, a change of +7.08 percentage points. The latest reported quarter, Q2 2026, shows 51.37%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Merit Medical Systems filings at SEC.gov ↗